VAERS Explorer
Back to explore

Report #2854172

Received Aug 14, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
VA
Recovered
Unknown
Vaccinated
Jun 18, 2025
Onset
Jun 18, 2025
Days to onset
0
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
VARCELVARICELLA (VARIVAX)MERCK & CO. INC.UNKY019318—
VARCELVARICELLA (VARIVAX)MERCK & CO. INC.UNK——

Symptoms (2)

No adverse eventProduct storage error

Symptom narrative

No symptoms or side effects were reported by HCP.; HCP reporting that a patient received a dose of improperly stored VARIVAX; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 18-JUN-2025, the patient was vaccinated with improperly stored dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), Injection (lot #Y019318 was valid, expiration date: 21-NOV-2026, 0.5 mL, route of administration and anatomical location were not provided) with sterile diluent (MERCK STERILE DILUENT) for prophylaxis (Product storage error). Temperature excursion of 52.2 F was reported. No symptoms or side effects were reported (No adverse event). No product quality complaint (PQC).